• Temesgen Tamirat, Kifle Woldemichael, Tsegaye Tewelde, and Tariku Laelago.
• Wachemo university, Hosanna, Ethiopia.
• Afr Health Sci. 2020 Jun 1; 20 (2): 560-567.

BackgroundRecent increases in access to HAART have made the management of drug toxicities an increasingly crucial component of HIV care in developing countries. The aim of this study was to determine prevalence of antiretroviral therapy adverse drug reactions and associated factors among HIV-infected adult patients at Nigist Eleni Mohammed memorial hospital.MethodsA cross sectional study was conducted by retrospective review of patients' medical records. From a total 721 adult patient records, 231 patients record were selected by simple random sampling technique. The study was conducted April 15-25, 2015.The association between dependent and independent variables was measured by using OR at 95% CI. P-value <0.05 was considered as statistically significant.ResultAbout 53(22.9%) patients developed ADRs (adverse drug reactions). Female (AOR=2.72, CI=1.177-6.30), patients with WHO stage III and IV (AOR= 13.06, CI=4.17-40.90) were found more likely to develop ADRs. Commonly identified ADRs were fatigue (18.1%), diarrhea (7.7%), nausea (6.5%), headache (3.6%) and anemia (2%).ConclusionNearly one in five patients develop ADRs. Sex of respondents, WHO stage and functional status were associated with ADRs. The health care providers should give due attention to ambulatory, bedridden, and WHO stage III and IV patients.© 2020 Tamirat T et al.

26 keywords...

hide…